Challenges in targeting MDSCs include their heterogeneity and the dynamic nature of their interactions within the tumor microenvironment. Additionally, the identification of specific and effective targets without affecting other critical myeloid functions is complex. However, ongoing research continues to uncover new insights and potential therapeutic targets.
